PTI Proteostasis Therapeutics Inc.

1.95
+0.02  (1%)
Previous Close 1.93
Open 1.92
Price To book 1.28
Market Cap 49171372
Shares 25,216,088
Volume 12,081
Short Ratio 3.15
Av. Daily Volume 105,311

SEC filingsSee all SEC filings

  1. 8-K - Current report 171203616
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171203037
  3. 8-K - Current report 171166147
  4. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 171128836
  5. 8-K - Current report 171098701

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 28-day data due 4Q 2017.
PTI-428
Cystic fibrosis

SEC Filings

  1. 8-K - Current report 171203616
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 171203037
  3. 8-K - Current report 171166147
  4. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 171128836
  5. 8-K - Current report 171098701
  6. 8-K - Current report 171097783
  7. 8-K - Current report 171008871
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 171008644
  9. 8-K - Current report 17993513
  10. 8-K - Current report 17993469